Infections with multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex bacteria complicate the care of U.S. military personnel and civilians worldwide. One hundred thirty-three isolates from 89 patients at our facility during 2006 and 2007 were tested by disk diffusion, Etest, and broth microdilution for susceptibility to tetracycline, doxycycline, minocycline, and tigecycline. Minocycline was the most active in vitro, with 90% of the isolates tested susceptible. Susceptibilities varied significantly with the testing method. The acquired tetracycline resistance genes tetA, tetB, and tetA(39) were present in the isolates.
Multidrug-resistant Acinetobacter baumannii-Acinetobacter calcoaceticus complex bacteria cause infections in traumatic wounds in U.S. military personnel injured in Iraq and Afghanistan (9) . A previous study of isolates recovered at our facility during 2003 to 2005 found these isolates to be highly susceptible to minocycline (6) , and our clinical experience with minocycline for the treatment of these infections has been favorable (5) . The possibility of increasing resistance to minocycline is of concern, as it would further restrict therapeutic options for multidrug-resistant isolates and may necessitate the use of agents with a greater potential for toxicity, such as colistin. Tigecycline has been proposed as a therapeutic option for multidrug-resistant A. baumannii-A. calcoaceticus complex infections (Tygacil package insert, Wyeth Pharmaceuticals, 2005), but its in vitro activity against isolates of military origin is uncertain.
The antibiogram for tetracycline, doxycycline, minocycline, and tigecycline was determined by using 133 clinical isolates from blood and wound infections of 89 patients admitted to our facility in 2006 were confirmed to be members of the A. baumannii-A. calcoaceticus complex by amplification of bla OXA-51-like ␤-lactamase genes and by amplified ribosomal DNA restriction analysis (ARDRA) with the restriction enzymes AluI, HinfI, HhaI, RsaI, MboI, and MspI (12, 13) .
The presence of tetracycline resistance genes in 89 singlepatient isolates was determined by PCR amplification for the tetA, tetB, tetH, tetL, tetM, tetA(39), and tetA(41) genes with previously published primer sequences by previously described methods (1, 8, 11) . Data were analyzed according to susceptibility phenotype, PFGE type, and Acinetobacter species as determined by ARDRA.
Consistent with our clinical experience and prior laboratory observations, minocycline had the highest in vitro activity, reflected in the MICs for 50 and 90% of the strains tested (MIC 50 and MIC 90 , respectively) and the percentage of isolates susceptible according to the broth microdilution method (Table 1) . The in vitro activities of tetracycline and doxycycline were low. The modal MIC of minocycline was more favorable than that of tigecycline.
The accuracy of the disk diffusion and Etest methods was evaluated by comparing the results of 133 isolates tested by these methods to the reference method of broth microdilution (Table 2) . Minocycline susceptibility varied widely by testing method, from 36.8% by disk diffusion to 88.7% by broth microdilution. No very major errors were observed. Etest committed fewer major errors than disk diffusion for doxycycline, while the methods were equivalent for minocycline. Etest committed fewer minor errors than disk diffusion for tetracycline and minocycline. There was no predominating type of minor error for either testing method (data not shown).
The accuracy of disk diffusion testing for determining minocycline susceptibility was poor. By this method, 51% of the isolates in this study would have been incorrectly reported as nonsusceptible to minocycline. This likely occurred due to clustering of the inhibitory zone diameter at or near the susceptibility breakpoint for minocycline in many isolates. Utilizing the Etest would have incorrectly reported 18% of the isolates as nonsusceptible to minocycline, a considerable improvement over disk diffusion but still exceeding the allowable limits of the CLSI (2). High disk diffusion error rates for Acinetobacter have been previously reported for tetracycline (10) and tigecycline (7) .
We observed 24 distinct PFGE types among the 89 singlepatient isolates. Approximately two-thirds of the isolates were represented by four PFGE types (Table 3) , composed of A. baumannii, A. calcoaceticus, or isolates that were indistinguishable between these by ARDRA (considered to be A. baumannii-A. calcoaceticus complex isolates). All isolates carried the bla OXA-51-like ␤-lactamase gene. Three PFGE types comprising 61% of the isolates were associated with a minocycline MIC 90 within the susceptible range. Among these three PFGE types, the percentages of isolates susceptible to tetracycline, doxycycline, and minocycline were 0, 18.5, and 100%, respectively.
The tetracycline resistance determinants tetH, tetL, tetM, and tetA(41) were not found in any isolates. The frequencies of tetA, tetB, and tetA(39) increased with advancing resistance phenotype but were less common in the most resistant phenotype. tetA was predominantly found in PFGE type 2 (A. baumannii). tetB was found in all species and was more common in the less frequent PFGE types. tetA(39) was abundant in PFGE type 1 (A. baumannii-A. calcoaceticus complex) isolates retaining susceptibility to minocycline. tetB was found in isolates resistant to all of the agents tested, as well as in isolates retaining susceptibility to minocycline. Multidrug-resistant A. baumannii-A. calcoaceticus complex bacteria remain an important cause of infection around the world. Minocycline is active against isolates of military origin, even when susceptibility to other tetracyclines and tigecycline has been lost. Determining minocycline susceptibility is hampered by important differences in accuracy between susceptibility testing methods, with the disk diffusion method significantly underestimating the proportion of susceptible isolates. Thus, in cases of infection with multidrug-resistant A. baumannii-A. calcoaceticus complex bacteria where minocycline therapy is desirable, it may be prudent to perform broth microdilution testing to obtain the most accurate susceptibility determination.
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